Short Position for SPL shares at 19-11-2018, page-23

JS......it really does not matter........if this is in trials next week, in a fortnight, or January

The price is going one way only.......up

As Jackie stated multiple sites have been selected with multiple cancers to be studied with the Dep Azd0466 drug

Everything is in place

It is imminent

What really gets me drooling is the total milestone and royalty payments over the licensed period (as quoted by CEO) is over $2,000,000,000

I did it in numerals because it looks so impressive (two billion dollars)

The current market capitalisation of Starpharma is around 480 - 500 million

So this one drug alone.......if successful is equal to 4 x market capitalisation

And Starpharma platform can be relevant to 75% of drugs currently being sild globally

You just have to do the sums

Mindboggling as far as I'm concerned

Exciting is an adjective which highlights the upcoming calendar year for Starpharma and it stakeholders